Viridian Therapeutics, Inc. VRDN Incentive stock program, shares reserved for future grants (in shares)
Incentive stock program, shares reserved for future grants (in shares) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares)?
- Viridian Therapeutics, Inc. (VRDN) reported incentive stock program, shares reserved for future grants (in shares) of $6.7M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares) changed year-over-year?
- Viridian Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares) increased by 196.8% year-over-year, from $2.26M to $6.7M.